Osteoporosis: a review and its dental implications.
Identifieur interne : 000B43 ( Ncbi/Checkpoint ); précédent : 000B42; suivant : 000B44Osteoporosis: a review and its dental implications.
Auteurs : John S. Mattson [États-Unis] ; D Roselyn Cerutis ; Lawrence C. ParrishSource :
- Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995) [ 1548-8578 ] ; 2002.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Cardiopathies (), Densité osseuse (physiologie), Diphosphonates (usage thérapeutique), Essais contrôlés randomisés comme sujet, Femelle, Fractures osseuses (étiologie), Hormonothérapie substitutive, Humains, Maladies parodontales (), Modulateurs sélectifs des récepteurs des oestrogènes (usage thérapeutique), Mâchoire édentée (), Mâle, Méthode en double aveugle, Oestrogénothérapie substitutive, Ostéoporose (), Ostéoporose (diagnostic), Ostéoporose (physiopathologie), Ostéoporose (traitement médicamenteux), Ostéoporose post-ménopausique (), Ostéoporose post-ménopausique (diagnostic), Ostéoporose post-ménopausique (traitement médicamenteux), Parodontite (), Perte d'attache parodontale (), Perte dentaire (), Placebo, Résorption alvéolaire (), Sujet âgé.
- MESH :
- diagnostic : Ostéoporose, Ostéoporose post-ménopausique.
- physiologie : Densité osseuse.
- physiopathologie : Ostéoporose.
- traitement médicamenteux : Ostéoporose, Ostéoporose post-ménopausique.
- usage thérapeutique : Diphosphonates, Modulateurs sélectifs des récepteurs des oestrogènes.
- étiologie : Fractures osseuses.
- Adulte d'âge moyen, Cardiopathies, Essais contrôlés randomisés comme sujet, Femelle, Hormonothérapie substitutive, Humains, Maladies parodontales, Mâchoire édentée, Mâle, Méthode en double aveugle, Oestrogénothérapie substitutive, Ostéoporose, Ostéoporose post-ménopausique, Parodontite, Perte d'attache parodontale, Perte dentaire, Placebo, Résorption alvéolaire, Sujet âgé.
English descriptors
- KwdEn :
- Aged, Alveolar Bone Loss (complications), Bone Density (physiology), Diphosphonates (therapeutic use), Double-Blind Method, Estrogen Replacement Therapy, Female, Fractures, Bone (etiology), Heart Diseases (prevention & control), Hormone Replacement Therapy, Humans, Jaw, Edentulous (prevention & control), Male, Middle Aged, Osteoporosis (complications), Osteoporosis (diagnosis), Osteoporosis (drug therapy), Osteoporosis (physiopathology), Osteoporosis, Postmenopausal (complications), Osteoporosis, Postmenopausal (diagnosis), Osteoporosis, Postmenopausal (drug therapy), Periodontal Attachment Loss (complications), Periodontal Diseases (complications), Periodontitis (complications), Placebos, Randomized Controlled Trials as Topic, Selective Estrogen Receptor Modulators (therapeutic use), Tooth Loss (prevention & control).
- MESH :
- chemical , therapeutic use : Diphosphonates, Selective Estrogen Receptor Modulators.
- complications : Alveolar Bone Loss, Osteoporosis, Osteoporosis, Postmenopausal, Periodontal Attachment Loss, Periodontal Diseases, Periodontitis.
- diagnosis : Osteoporosis, Osteoporosis, Postmenopausal.
- drug therapy : Osteoporosis, Osteoporosis, Postmenopausal.
- etiology : Fractures, Bone.
- physiology : Bone Density.
- physiopathology : Osteoporosis.
- prevention & control : Heart Diseases, Jaw, Edentulous, Tooth Loss.
- Aged, Double-Blind Method, Estrogen Replacement Therapy, Female, Hormone Replacement Therapy, Humans, Male, Middle Aged, Placebos, Randomized Controlled Trials as Topic.
Abstract
Osteoporosis is a disease that affects primarily women, but can also occur in men. It is characterized by a loss of bone mineral density (BMD), and often culminates in a fracture of the hip, wrist, and/or vertebrae. The diagnosis of osteoporosis is often made by using bone density measurements. They are often expressed in relative terms (T-scores and Z-scores); the Z-score is the number of standard deviations from the age-matched average value of healthy women. A low Z-score indicates the bone density is lower than it should be for a patient's age and sex. Osteoporosis is defined as a BMD loss of 2.5 standard deviations or more below the established mean. Osteoporosis can be treated by a variety of methods, the most common being the use of estrogen, with or without progestin or progesterone. The use of estrogen alone is referred to as estrogen replacement therapy (ERT), and the combination hormone replacement therapy (HRT). Other drugs used in the treatment of osteoporosis are the selective estrogen receptor modulators (SERMs) and the bisphosphonates. The SERMs appear to offer many of the positive benefits of estrogen with fewer adverse effects on the breast or uterus. Recently, a randomized, double blind study of nearly 3,000 women found no overall benefit in reducing heart disease for those taking estrogen. In fact, in the first year of estrogen use, heart disease was higher in this group than in those taking placebo. The relationship between systemic BMD and periodontal status has been investigated. In some patients, there is a correlation between a decrease of mandibular bone mass and tooth loss. In others, there is no such correlation. Those postmenopausal women taking HRT had greater tooth retention and a reduced likelihood of edentulism. A recent study has found no correlation between clinical attachment levels and the BMD of the lumbar spine. Many possible factors contribute to the development of osteoporosis and periodontal diseases. It is difficult to establish a direct correlation between tooth loss, bone loss, and loss of attachment resulting from periodontitis and decreased BMD associated with osteoporosis, but studies are ongoing.
PubMed: 12526189
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003090
- to stream PubMed, to step Curation: 003090
- to stream PubMed, to step Checkpoint: 003090
- to stream Ncbi, to step Merge: 000B43
- to stream Ncbi, to step Curation: 000B43
Links to Exploration step
pubmed:12526189Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Osteoporosis: a review and its dental implications.</title>
<author><name sortKey="Mattson, John S" sort="Mattson, John S" uniqKey="Mattson J" first="John S" last="Mattson">John S. Mattson</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Periodontics, Creighton University School of Dentistry, Omaha, Nebraska, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Periodontics, Creighton University School of Dentistry, Omaha, Nebraska</wicri:regionArea>
<placeName><region type="state">Nebraska</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cerutis, D Roselyn" sort="Cerutis, D Roselyn" uniqKey="Cerutis D" first="D Roselyn" last="Cerutis">D Roselyn Cerutis</name>
</author>
<author><name sortKey="Parrish, Lawrence C" sort="Parrish, Lawrence C" uniqKey="Parrish L" first="Lawrence C" last="Parrish">Lawrence C. Parrish</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12526189</idno>
<idno type="pmid">12526189</idno>
<idno type="wicri:Area/PubMed/Corpus">003090</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003090</idno>
<idno type="wicri:Area/PubMed/Curation">003090</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003090</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003090</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003090</idno>
<idno type="wicri:Area/Ncbi/Merge">000B43</idno>
<idno type="wicri:Area/Ncbi/Curation">000B43</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B43</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Osteoporosis: a review and its dental implications.</title>
<author><name sortKey="Mattson, John S" sort="Mattson, John S" uniqKey="Mattson J" first="John S" last="Mattson">John S. Mattson</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Periodontics, Creighton University School of Dentistry, Omaha, Nebraska, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Periodontics, Creighton University School of Dentistry, Omaha, Nebraska</wicri:regionArea>
<placeName><region type="state">Nebraska</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cerutis, D Roselyn" sort="Cerutis, D Roselyn" uniqKey="Cerutis D" first="D Roselyn" last="Cerutis">D Roselyn Cerutis</name>
</author>
<author><name sortKey="Parrish, Lawrence C" sort="Parrish, Lawrence C" uniqKey="Parrish L" first="Lawrence C" last="Parrish">Lawrence C. Parrish</name>
</author>
</analytic>
<series><title level="j">Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)</title>
<idno type="ISSN">1548-8578</idno>
<imprint><date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Alveolar Bone Loss (complications)</term>
<term>Bone Density (physiology)</term>
<term>Diphosphonates (therapeutic use)</term>
<term>Double-Blind Method</term>
<term>Estrogen Replacement Therapy</term>
<term>Female</term>
<term>Fractures, Bone (etiology)</term>
<term>Heart Diseases (prevention & control)</term>
<term>Hormone Replacement Therapy</term>
<term>Humans</term>
<term>Jaw, Edentulous (prevention & control)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Osteoporosis (complications)</term>
<term>Osteoporosis (diagnosis)</term>
<term>Osteoporosis (drug therapy)</term>
<term>Osteoporosis (physiopathology)</term>
<term>Osteoporosis, Postmenopausal (complications)</term>
<term>Osteoporosis, Postmenopausal (diagnosis)</term>
<term>Osteoporosis, Postmenopausal (drug therapy)</term>
<term>Periodontal Attachment Loss (complications)</term>
<term>Periodontal Diseases (complications)</term>
<term>Periodontitis (complications)</term>
<term>Placebos</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Selective Estrogen Receptor Modulators (therapeutic use)</term>
<term>Tooth Loss (prevention & control)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Cardiopathies ()</term>
<term>Densité osseuse (physiologie)</term>
<term>Diphosphonates (usage thérapeutique)</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Femelle</term>
<term>Fractures osseuses (étiologie)</term>
<term>Hormonothérapie substitutive</term>
<term>Humains</term>
<term>Maladies parodontales ()</term>
<term>Modulateurs sélectifs des récepteurs des oestrogènes (usage thérapeutique)</term>
<term>Mâchoire édentée ()</term>
<term>Mâle</term>
<term>Méthode en double aveugle</term>
<term>Oestrogénothérapie substitutive</term>
<term>Ostéoporose ()</term>
<term>Ostéoporose (diagnostic)</term>
<term>Ostéoporose (physiopathologie)</term>
<term>Ostéoporose (traitement médicamenteux)</term>
<term>Ostéoporose post-ménopausique ()</term>
<term>Ostéoporose post-ménopausique (diagnostic)</term>
<term>Ostéoporose post-ménopausique (traitement médicamenteux)</term>
<term>Parodontite ()</term>
<term>Perte d'attache parodontale ()</term>
<term>Perte dentaire ()</term>
<term>Placebo</term>
<term>Résorption alvéolaire ()</term>
<term>Sujet âgé</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Diphosphonates</term>
<term>Selective Estrogen Receptor Modulators</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Alveolar Bone Loss</term>
<term>Osteoporosis</term>
<term>Osteoporosis, Postmenopausal</term>
<term>Periodontal Attachment Loss</term>
<term>Periodontal Diseases</term>
<term>Periodontitis</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Osteoporosis</term>
<term>Osteoporosis, Postmenopausal</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Ostéoporose</term>
<term>Ostéoporose post-ménopausique</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Osteoporosis</term>
<term>Osteoporosis, Postmenopausal</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Fractures, Bone</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Densité osseuse</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Bone Density</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Ostéoporose</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Osteoporosis</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Heart Diseases</term>
<term>Jaw, Edentulous</term>
<term>Tooth Loss</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Ostéoporose</term>
<term>Ostéoporose post-ménopausique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Diphosphonates</term>
<term>Modulateurs sélectifs des récepteurs des oestrogènes</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Fractures osseuses</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Double-Blind Method</term>
<term>Estrogen Replacement Therapy</term>
<term>Female</term>
<term>Hormone Replacement Therapy</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Placebos</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Cardiopathies</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Femelle</term>
<term>Hormonothérapie substitutive</term>
<term>Humains</term>
<term>Maladies parodontales</term>
<term>Mâchoire édentée</term>
<term>Mâle</term>
<term>Méthode en double aveugle</term>
<term>Oestrogénothérapie substitutive</term>
<term>Ostéoporose</term>
<term>Ostéoporose post-ménopausique</term>
<term>Parodontite</term>
<term>Perte d'attache parodontale</term>
<term>Perte dentaire</term>
<term>Placebo</term>
<term>Résorption alvéolaire</term>
<term>Sujet âgé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Osteoporosis is a disease that affects primarily women, but can also occur in men. It is characterized by a loss of bone mineral density (BMD), and often culminates in a fracture of the hip, wrist, and/or vertebrae. The diagnosis of osteoporosis is often made by using bone density measurements. They are often expressed in relative terms (T-scores and Z-scores); the Z-score is the number of standard deviations from the age-matched average value of healthy women. A low Z-score indicates the bone density is lower than it should be for a patient's age and sex. Osteoporosis is defined as a BMD loss of 2.5 standard deviations or more below the established mean. Osteoporosis can be treated by a variety of methods, the most common being the use of estrogen, with or without progestin or progesterone. The use of estrogen alone is referred to as estrogen replacement therapy (ERT), and the combination hormone replacement therapy (HRT). Other drugs used in the treatment of osteoporosis are the selective estrogen receptor modulators (SERMs) and the bisphosphonates. The SERMs appear to offer many of the positive benefits of estrogen with fewer adverse effects on the breast or uterus. Recently, a randomized, double blind study of nearly 3,000 women found no overall benefit in reducing heart disease for those taking estrogen. In fact, in the first year of estrogen use, heart disease was higher in this group than in those taking placebo. The relationship between systemic BMD and periodontal status has been investigated. In some patients, there is a correlation between a decrease of mandibular bone mass and tooth loss. In others, there is no such correlation. Those postmenopausal women taking HRT had greater tooth retention and a reduced likelihood of edentulism. A recent study has found no correlation between clinical attachment levels and the BMD of the lumbar spine. Many possible factors contribute to the development of osteoporosis and periodontal diseases. It is difficult to establish a direct correlation between tooth loss, bone loss, and loss of attachment resulting from periodontitis and decreased BMD associated with osteoporosis, but studies are ongoing.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Nebraska</li>
</region>
</list>
<tree><noCountry><name sortKey="Cerutis, D Roselyn" sort="Cerutis, D Roselyn" uniqKey="Cerutis D" first="D Roselyn" last="Cerutis">D Roselyn Cerutis</name>
<name sortKey="Parrish, Lawrence C" sort="Parrish, Lawrence C" uniqKey="Parrish L" first="Lawrence C" last="Parrish">Lawrence C. Parrish</name>
</noCountry>
<country name="États-Unis"><region name="Nebraska"><name sortKey="Mattson, John S" sort="Mattson, John S" uniqKey="Mattson J" first="John S" last="Mattson">John S. Mattson</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B43 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000B43 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= EdenteV2 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= pubmed:12526189 |texte= Osteoporosis: a review and its dental implications. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:12526189" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a EdenteV2
![]() | This area was generated with Dilib version V0.6.32. | ![]() |